LY-3475070

• Description :

  LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  286.33

• Molecular Formula :

  C15H18N4O2

• Notes :

  Research use only, not for human use.

• Receptor :

  CD73

• CAS Number :

  2375815-63-5